19815 Bay Branch Rd
Andalusia, Alabama 36420
(334) 222-2525



Facebook    

 

SCAMHC is an approved Mental Health site for the National Health Service Corps Loan Repayment program.  Find out the program details and see if you qualify by visiting: http://nhsc.hrsa.gov/

SCAMHC is an Equal Opportunity Provider and Employer and maintains a Drug-Free Workplace


powered by centersite dot net
Depression: Depression & Related Conditions
Resources
Basic Information
Introduction and Types of Depressive DisordersRelated Disorders / ConditionsHistorical and Current UnderstandingsBiology, Psychology and SociologyTreatment - Medication and PsychotherapyAlternative Medicine and Self-Help ResourcesSpecial IssuesReferences
More InformationTestsLatest News
Regular Leisure-Time Exercise May Cut Incidence of DepressionMoving Just 1 Hour a Week May Curb Depression RiskHealth Tip: Do You Need Psychological Therapy?Psychosocial Intervention Ups Adherence to AntidepressantsPostpartum Depression Likely to Recur With Future PregnanciesCancer Patients May Have Undiagnosed DepressionMom-to-Be's Antidepressants Tied to Kids' Psychiatric WoesToo Many New Mothers Silent on Postpartum Depression1 in 5 Moms Mum About Post-Pregnancy BluesGoogle Search for 'Depression' Now to Provide Screening TestAre Depressed Teens Prone to Violence?Antidepressants Used by 12.7 Percent of Those Age ≥12 in U.S.U.S. Antidepressant Use Jumps 65 Percent in 15 YearsSmoking During Pregnancy Up Among Women With DepressionDepression After Coronary Artery Disease Diagnosis Ups Death RiskYoga May Help Ease DepressionToo Soon to Widely Recommend Ketamine for DepressionLonger Estrogen Exposure May Protect Against DepressionEstrogen May Influence Women's Depression RiskLosing Medicaid Tough on People Battling Depression: StudyLink for Maternal Antidepressant, Kids' Brain Health QuestionedAddition of Aripiprazole Ups Major Depressive Disorder RemissionNo Sign That Antidepressants in Pregnancy Harm Kids' Brains: StudyMed Switch Not Always Best Choice With Tough DepressionDepression Contributes to Health Decline Seen in Cancer CaregiversDepression May Worsen Health for Cancer CaregiversElectric Brain Stimulation No Better Than Meds For Depression: StudyDepression Inversely Linked to Body Composition in TeensReview: Depression Screening As Inpatient Important, FeasibleDepression Can Slow Hospital Patients' Recovery: StudyAntidepressants During Pregnancy Safe for Baby: StudyChronic Pain Common in Adults With Depression, AnxietyWhat You Need to Know About AntidepressantsAPA: Internet-Based CBT Can Be Helpful in DepressionCan Online Treatment Replace Your Therapist?Depression Often a Precursor to Falls in Elderly PeopleOverweight in Childhood May Up Lifetime Risk of DepressionHeavy Kids Face Triple the Odds for Depression in AdulthoodObesity, Sex Predict Remission for Antidepressant MedicationsGender Differences in Depression Tend to Appear About Age 12Depression's Gender Gap Shows Up in Pre-Teen YearsStudies Question Link Between Mom's Antidepressant Use, Autism in KidsMortality Up With Depression Just Before Breast Cancer DiagnosisDepressive Disorders Up With Antimuscarinics for OABTrauma as a Teen May Boost Depression Risk Around MenopauseBlood Test Promising for ID of Early Depression, SchizophreniaBlood Test Might Someday Distinguish Early Depression, SchizophreniaHold That Pose: Yoga May Ease Tough DepressionDepression May Hasten Death in Years After Heart DiagnosisAntidepressant Efficacy Varies for Depressive Symptom Clusters
Questions and AnswersVideosLinksBook Reviews
Related Topics

Anxiety Disorders
Bipolar Disorder
Suicide
Addictions: Alcohol and Substance Abuse
Pain Management

Blood Test Might Someday Distinguish Early Depression, Schizophrenia

HealthDay News
by -- Mary Elizabeth Dallas
Updated: Mar 14th 2017

new article illustration

TUESDAY, March 14, 2017 (HealthDay News) -- It's often difficult for doctors to tell the difference between depression and schizophrenia, especially early on.

Now, researchers say they're on the trail of a blood test that might be able to do just that.

"This is the first objective, physiological marker for two major psychiatric disorders that, once fully developed into a clinical test, can allow for earlier and more accurate diagnosis, and selection of more appropriate medications for patients," study co-author Dr. Handan Gunduz-Bruce said in a news release from The Physiological Society.

Gunduz-Bruce is a schizophrenia researcher at the Yale School of Medicine.

One psychiatrist agreed that such a test is needed.

"It can be very difficult to diagnose depression and schizophrenia, especially when they onset in the adolescent years," said Dr. Scott Krakower, assistant chief of psychiatry at Zucker Hillside Hospital in Glen Oaks, N.Y.

"Symptoms may not be as clear and the patient may not exhibit all symptoms of the disease," Krakower added. He believes an early diagnostic test "may help us one day quickly diagnose complex cases and offer earlier intervention for our patients."

According to the Yale team, animal research had already shown that the release of a hormone called arginine-vasopressin (AVP) relies on a cellular process known as NMDA receptor signaling.

NMDA is a brain cell receptor for glutamate -- a chemical that delivers messages between brain cells and may play a role in depression.

NMDA receptor signaling appears to be increased in people with depression but reduced in those with schizophrenia, the study authors explained.

For the study, the research team gave volunteers a highly concentrated salt solution. This solution is designed to trigger the release of AVP. The researchers then tested each patients' blood for AVP.

The researchers found that AVP release among those with depression was different from those with schizophrenia. Depressed patients had a greater release of the hormone, while people with schizophrenia had a decreased production.

According to the researchers, the findings could lead to a test that might help identify certain forms of depression and schizophrenia.

Since the two conditions often have vague and mild symptoms early on, such a test might enable patients to be diagnosed sooner and receive more appropriate treatment, the researchers said.

Still, that day may be a long way off -- the researchers said they haven't yet developed a test that could be used outside of their lab.

Dr. Ami Baxi directs inpatient psychiatry at Lenox Hill Hospital in New York City. She agreed with Krakower that "although this method will not capture everybody with depression or schizophrenia, it is a step towards earlier and more accurate diagnosis with potential for targeted treatment options."

The study was published March 13 in the journal Experimental Physiology.

More information

The U.S. National Institute of Mental Health provides more information on schizophrenia.